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Abstract
Aim The current COVID-19 pandemic is challenging
healthcare systems at a global level. We provide a practi-
cal strategy to reorganize pathways of emergency and
elective colorectal surgery during the COVID-19 pan-
demic.
Method The authors, all from areas affected by the
COVID-19 emergency, brainstormed remotely to
define the key-points to be discussed. Tasks were
assigned, concerning specific aspects of colorectal sur-
gery during the pandemic, including the administrative
management of the crisis in Italy. The recommenda-
tions (based on experience and on the limited evidence
available) were collated and summarized.
Results Little is known about the transmission of
COVID-19, but it has shown a rapid spread. It is pru-
dent to stop non-cancer procedures and prioritize
urgent cancer treatment. Endoscopy and proctological
procedures should be performed highly selectively.
When dealing with colorectal emergencies, a conserva-
tive approach is advised. Specific procedures should be
followed when operating on COVID-19-patients, using
dedicated personal protective equipment and adhering
to specific rules. Some policies are described, including
minimally-invasive surgery. These policies outline the
strict regulation of entry/ exit into theatres and operat-
ing building as well as advice on performing procedures
safely to reduce risk of spreading the virus. It is likely
that a reorganization of health system is required, both
at central and local levels. A description of the strategy
adopted in Italy is provided.
Conclusion Evidence on the management of patients
needing surgery for colorectal conditions during the
COVID-19 pandemic is currently lacking. Lessons
learnt from healthcare professionals that have managed
high volumes of surgical patients during the pandemic
could be useful to mitigate some risks and reduce expo-
sure to other patients, public and healthcare staff.
Keywords Colorectal surgery, complications, COVID-
19, emergency, health policy
What does this paper add to the literature?
COVID-19 pandemic is stressing healthcare system
globally and threatens the ability to offer full and ade-
quate care to patients. Limited data is available concern-
ing the management of colorectal patients during the
emergency. This manuscript contains practical tips to
face the crisis, hoping to mitigate its impact on colorec-
tal patients and healthcare professionals.
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‘There is nothing new in the story. [. . .]. Want of
foresight, unwillingness to act when action would be
simple and effective, lack of clear thinking, confusion
of counsel until the emergency comes, until self-
preservation strikes its jarring gong’
Winston Churchill
Introduction
The outbreak of SARS-CoV2 infection, responsible for
the clinical manifestations named Corona Virus Disease
2019 or COVID-19 by the World Health Organisation,
became a pandemic on the 12th March 2020. A combi-
nation of unreadiness in containing the first cases and
of the aggressiveness of the virus itself, along with an
underestimation of the problem during the early phases
of the outbreak, resulted in the extremely rapid diffu-
sion of COVID-19 globally, before effective measures
to contain the infection had been developed.
Italy suffered the deepest impact, and its Health Sys-
tem is currently being severely tested by COVID-19.
After an initial attempt to contain the outbreak (which
mainly involved the North of Italy) with usual methods
of response to a contagious, infective disease, it became
apparent that more stringent measures were needed.
The Italian Government announced the forced isolation
of citizens for a period of 14 days, in order to reduce
social contact to the lowest level possible. This was
deemed the safest action in view of the absence of a
vaccine and very little data on the pathophysiology and
course of the infection. Notwithstanding the stringent
measures adopted, a further 69 000 individuals tested
positive in Italy by the 26th March 2020 with more
than 6800 deaths [1]; approximately 6% of those
infected required intensive care. A similar trend has
been observed later in Spain, which adopted the similar
‘strict’ strategy that Italy advocated, closing land bor-
ders to all foreigners excluding people living or working
in Spain, effective of the 17th March 2020 [2]. In the
United Kingdom, the Government initially decided not
to restrict social contacts, based on the concept of
favouring acquired immunity, a statement signed by
many UK scientists criticized this policy, advocating to
enforce social distancing [3]. A stricter isolation policy
is now in effect in the UK. It is likely that similar deci-
sions will follow in the next days in the other European
Countries.
As the number of people positive for COVID-19 are
exceeding 740 000 cases in 196 countries, of whom
approximately 28% had an outcome, and have caused
over 35 000 deaths (30th March 2020), and consider-
ing that the actual rate of patients affected is difficult to
be accurately predicted (due to the different policies in
COVID-19 testing globally), it is necessary to plan
prompt actions to be taken, in order to face the
COVID-19 challenge appropriately.
The impact on those who have contracted COVID-
19, patients with cancer or with chronic conditions,
patients scheduled to undergo elective non-cancer pro-
cedures, as well as on healthcare professionals (called to
work in a completely unusual and critical scenario), is
enormous [4,5]. There is an urgent need to re-group
and rethink the way the surgical care is being offered,
especially when dealing with colorectal surgery.
The aim of the authors, who were profoundly
involved in the response to the pandemic in their own
country of practice, was to provide the readers with
practical information and instructions on how to deal
with COVID-19 from a surgeon’s perspective, with par-
ticular focus on colorectal diseases. Given the lack of
high-quality evidence on the COVID-19 and the rapid
evolution of the pandemic; the readers should be aware
that some of the recommendations in the present article
are opinions or based on expert experience of the pan-
demic.
COVID-19 consequences on elective
management of colorectal cancer and
inflammatory bowel diseases
COVID-19 pandemic is stressing every aspect of differ-
ent healthcare systems worldwide. Whilst the greatest
priority is currently the treatment of COVID-19 cases,
the population continues to suffer from all the same dis-
eases that existed prior to the COVID-19 outbreak. In
colorectal surgery, the most affected categories of
patients are those diagnosed with cancer and inflamma-
tory bowel diseases (IBD). Whether patients with gas-
trointestinal cancers are more likely to be infected with
COVID-19 compared with healthy individuals, remains
to be elucidated. In a nationwide analysis from China,
18 (1%) of 1590 COVID-19 cases had a history of can-
cer; among these 18 cases, three (16.7%) had a history
of colorectal cancer [4]. Patients with COVID-19 and
previous or active cancers seemed to have more serious
adverse events [4]. According to data coming from the
Italian National Institute of Health (Istituto Superiore di
Sanita, ISS), out of a total of 2003 COVID-19-related
deaths that occurred in Italy until March 17th, 2020,
72 patients (20.3%) had a history of active cancer in the
last 5 years [6]. These figures should be interpreted
with caution, as they do not represent the totality of
the cases, therefore it is not possible at present to estab-
lish if cancer patients are at higher risk of death from
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COVID-19, but a higher rate of complications could be
expected.
These considerations raise management issues, in
addition to the clinical challenges. Several measures
have been implemented in Italy to optimize the man-
agement of colorectal cancer patients [7]. In severely
hit areas, like Lombardy and other northern Italian
regions, staff shortages and overwhelming workload in
emergency departments, intensive care units and
COVID-19 dedicated wards required the reallocation of
surgeons. All elective non-cancer procedures and outpa-
tient clinics are suspended.
After the announcement of restrictive measures to
reduce social contacts by the Italian Government, geo-
graphical location became even more relevant. Each
Italian Region followed a policy, based on the actual
extent of the outbreak locally. In Lombardy, some
“Hub” hospitals were established, including patients
with colorectal cancer, and patients were prioritized
based on patient- and disease-related factors. A detailed
description is reported in the “Healthcare policy and
Italian Government Perspective” section.
In patients who underwent surgery and were due to
receive adjuvant treatment, therapy is being postponed
on a case-by-case basis, when possible. In COVID-19-
positive patients, it would be prudent to defer elective
surgery, even if asymptomatic, due to the presumed risk
of worse outcome in the event of postoperative compli-
cations [8]. In areas with the highest infection rate,
patients requiring surgery are mandatorily being
screened for COVID-19 infection. Extra precautions
are encouraged for each patient, including wearing a
surgical mask and social distancing.
Patients with IBD have excessive immunological
responses and inflammation, often requiring immune
modulating or immunosuppressive drugs. Such treat-
ments expose patients to an increased risk of infections
and potentially increased susceptibility to COVID-19.
It is prudent to advice all patients under biologic
immunosuppressive therapies who are living in areas
with high density of COVID-19 cases, to adopt
enhanced protective measures such as social distancing,
frequent hand washing and disinfection with hydroalco-
holic gel, while maintaining their usual treatment [9].
Considering that viral infections (e.g. EBV, CMV)
could worsen IBD, it might be prudent to consider
reassessing patients and modulate biological treatment
as required. It is of outmost importance to consider the
possible implications associated with treatment with-
drawal, especially in terms of IBD flares – which might
have more severe consequences than COVID-19. The
International Organization for the Study of Inflamma-
tory Bowel Diseases (IOIBD) advice to maintain
treatment with mesalamine and taper steroids whenever
possible. For patients under thiopurines or JAK inhibi-
tors treatment, due to the long-standing immunomodu-
lator effect, their discontinuation would not be
beneficial in the short term. There is also no indication
to stop biologic therapies, provided that patients adhere
to enhanced recommendations [9,10]. According to
data coming from the seven largest IBD referral centres
in China with more than 20 000 IBD cases, currently
no patients with IBD tested positive for SARS-CoV-2.
Furthermore, no patients with IBD and COVID-19
have been reported from the three largest tertiary IBD
centres in Wuhan [4]. Furthermore, in a recent report
from Wuhan, 318 patients were recently contacted and
provided with self-preventative measures and had their
treatment adjusted to reduce the risk of COVID-19
infection [11]. By doing so, none of the patients
reported symptoms suggestive of COVID-19 and no
one tested positive for the virus, suggesting that such
pro-active strategies were effective in the short-term.
International collaborations and big data analysis
could provide a more comprehensive picture. A promis-
ing initiative of an international registry including paedi-
atric and adult IBD cases with SARS-CoV-2 infection
has been recently launched: the SECURE-IBD Coron-
avirus reporting registry (https://covidibd.org). The
aim is to help define the impact of COVID-19 on IBD
and how factors such as age, comorbidities, and IBD
treatments impact COVID-19 outcomes. All cases of
confirmed COVID-19 in IBD patients, are reported in
this registry, regardless of severity. Seven cases of
COVID-19 have been reported to the registry so far
(only one requiring hospitalization but no ventilator
support).
COVID-19 consequences on endoscopic
procedures
Endoscopy implies a high risk of COVID-19 transmis-
sion. Short physical distance among patients and
healthcare providers, aerosolization and aspiration of
digestive fluids, may contribute to the unrecognized
spread of the disease, especially from asymptomatic
patients [12]. In addition, ACE-2 receptor, binding
site for SARS-CoV-2, is highly expressed in the diges-
tive system [13] and viral RNA has been detected in
saliva [14] and stools [15,16], suggesting oral-faecal
transmission as a potential alternative route of conta-
gion.
Patients infected with COVID-19 can also develop
GI symptoms [17]. In a recent study [17], among 73
patients hospitalized for COVID-19 pneumonia, 39
(53.4%) tested positive for viral-RNA in the stools, with
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results still positive in 17 (23.3%) patients after virus
clearance in the respiratory samples. Zhang et al. [16]
suggested that the virus is detectable in the faecal sam-
ples of all positive patients, regardless of the severity of
illness and remains much longer in the stool than in
other specimens such as nasopharyngeal swabs and deep
throat saliva. Therefore, the authors conclude that stool
sample analysis may be useful in identifying asymp-
tomatic COVID-19-positive individuals. However,
knowledge of the disease is still limited, and many rec-
ommendations are based on assumptions derived from
previous SARS or MERS outbreaks [18].
After the detection of first coronavirus clusters in
Italy and the declaration of Italian Government of
national outbreak on 11 March 2020, firm recommen-
dations have been released, supported by the Italian
Society of Digestive Endoscopy (SIED) [19] with simi-
lar advice released by international societies in the fol-
lowing days. Figure 1 shows a potential reaction to
outbreak by an endoscopy department.
All routine endoscopies have been postponed and
will be rescheduled. Outpatient and follow-up visits
have been deferred or done by telemedicine or tele-
phone consultation [12,20]. We suggest avoiding any
rescheduling until a clear perspective about outbreak
escalation is known. Each case needs to be tracked and
periodically evaluated, in the light of pandemic
evolution, to decide if any further delay may increase
the risk for the patient.
Personnel should be strategically assigned, in the
perspective of an infection spread among hospital staff.
The minimum staff level strictly necessary to perform
urgent or undeferrable procedures should attend the
department. Students and trainees should not be
allowed to access the department to avoid unnecessary
risks [21] and overuse of personal protective equipment
(PPE).
Concomitant exposure of individuals with specialist
set skills needs to be avoided to preserve service conti-
nuity [22]. In low-resource settings, endoscopy proce-
dures may be reduced to only life-threatening GI
bleeding, foreign body removal, food bolus obstruction,
and ascending cholangitis [23].
Risk stratification of patients is paramount. We rec-
ommend telephone interview the day before the proce-
dure, asking for symptoms such as fever, cough and
dyspnoea. It is recommended that, before entering the
endoscopy department, all patients should be scanned
for fever (temperature> 37°) and undergo a triage ques-
tionnaire to stratify the risk associated with the proce-
dure [12,24]. Repici et al.[12] classified “low risk”
patients as those with no symptoms, no contact with
COVID-19, who did not stay or travel to areas at risk




1. REDUCE STAFF AT MINIMUM LEVEL;
2. CANCEL ALL UNNECESSARY ACTIVITIES (e.g. STUDENTS’ ROTATION,
TRAINING MEETINGS IN DEPARTMENT);
3. CREATE ALTERNATIVE TEAMS WITH EQUAL SKILL SETS
POSTPONE OUTPATIENT VISITS
OR ENCOURAGE PHONE/TELEMEDICINE CONSULTS
POSTPONE AND RESCHEDULE
1. STRATIFY THE RISK OF COVID-19
2. STANDARD PPE [LOW-RISK PATIENTS AND INTERMEDIATE RISK
PATIENTS (LOWER GI ENDOSCOPY)
3. ADVANCED PPE [HIGH RISK PATIENTS AND INTERMEDIATE RISK
PATIENTS (UPPER GI ENDOSCOPY)]
4. PERFORM ENDOSCOPY ON COVID-19 PATIENTS IN A NEGATIVE
PRESSURE ROOM (if available)
REASSESS IN VIEW OF OUTBREAK EVOLUTION
TRACK TEHM AND REDUCE DELAY IF THERE IS AN INCREASED
RISK FOR THE PATIENT (e.g. TUMOR BIOPSY FOR SURGERY OR
NEOADIUVANT THERAPY)








Figure 1 Endoscopy department reaction to COVID-19 outbreak. A suggested risk stratification pathway is reported in the text
[12]. PPE: Personal Protective Equipment.
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defined as those with symptoms (fever, cough, dysp-
noea, diarrhoea) but with no contact with COVID-19
or stay in high risk areas, or without symptoms but with
exposure to COVID-19 or stay in risk areas. “High
risk” patients were considered those with at least one
symptom and at least one of the following: contact with
COVID-19; stay in areas at risk during the previous
14 days [12].
Standard precautions (surgical mask, gloves in high
risk patients) are mandatory for patients and providers.
Relatives/caregivers must wait outside the department.
For low-risk patients (and intermediate risk patients
undergoing low GI endoscopy), surgical mask, single-
use gown, hairnet and eye protection (e.g. goggles) are
sufficient. For high-risk patients (and intermediate risk
patients undergoing upper GI endoscopy) filtering face
-piece (FFP) respirators, such as N95, FFP2/FFP3,
double-gloves, water-resistant gown and goggles must
be used [23].
A COVID route, completely separated from no-
COVID-19, must be clearly identified. A negative pres-
sure room outside the endoscopy department for
COVID or suspected COVID-19 patients needing
endoscopy is desirable. Caution must be paid when dis-
posing of PPE, scrubs and shoes used in the endoscopy
ward. In a study by Ong et al. [25] regarding environ-
mental contamination by SARS-CoV-2, positive samples
were found on staff shoes. Therefore, dedicated endo-
scopy shoes or disposable shoe covers are recommended
[26].
In regions with highest peaks of COVID-19 out-
break, endoscopy services have been centralized in few
referral centres in order to the reduce workload and to
increase the local response to the ingrowing number of
COVID-19 admissions.
COVID-19 consequences on proctology
Proctology and other benign disorders are a component
of colorectal surgery that has almost completely ceased
during the current pandemic. All outpatient proctology
clinics, with the exception of oncological and urgent
cases, have been postponed and are due to be resched-
uled gradually.
However, several proctology disorders represent a
serious psychosocial and economic burden for the
patients, sometimes comparable to a malignant disease.
Rectovaginal and rectourethral fistulas certainly belong
to this category, as well as pre-cancerous lesions and
anal malignancies. Not being able to perform diagnostic
procedures (including imaging and biopsy) raises ethical
concerns because their mortality rate, if not timely trea-
ted, could exceed the rate reported for COVID-19
[27,28]. Patients with sexually transmitted diseases
deserves special attention; treating them during the pan-
demic could increase the risk of postoperative complica-
tions due to a weakened immune system.
Digital rectal examination and anoscopy are impor-
tant steps of proctology examination, but the current
emergency forces surgeons to use them selectively, due
to the risk of contagion intrinsic to such manoeuvres.
Since elective outpatient appointments are not being
carried out, most consultants are conducting telephone
consultation after revising the charts of the patients,
and only those who are deemed not deferrable are
invited to attend the hospital. Implementation of tele-
medicine into everyday practice is probably something
to consider after resolution of the pandemic, as it could
avoid physical attendance of the hospital, unless
unavoidable [8]. It has indeed been shown that teleme-
dicine reduces healthcare costs by means of fewer hospi-
tal admissions and re-admissions [29]. The role of
telemedicine during disasters has been validated [30] as
well as its role in coloproctology [31,32].
Anorectal emergencies are common and include
thrombosed external haemorrhoids, strangulated or
bleeding haemorrhoids, anorectal abscesses, anal fissure,
and Fournier’s gangrene. Treatment of such conditions
should be timely provided, even if surgery is not always
necessary. Any attempt should be made to manage the
patients conservatively, especially if the suspicion of
COVID-19-positivty is high or the patient is known to
be affected. Conservative measures are possible and
effective for thrombosed haemorrhoids [33], whereas
anorectal septic conditions should be promptly treated
with surgical drainage. Fournier’s gangrene has an esti-
mated incidence below 1% of all anorectal sepsis, but its
mortality rate ranges between 25% and 73% [34],
thereby requiring immediate diagnosis and treatment as
a priority. In the case of proctology procedures during
the pandemic, outpatient procedures and local anaesthe-
sia should be favoured.
COVID-19 and emergency colorectal
surgery with perioperative practice
recommendations on how to safely scrub
and protective measures/equipment
Emergency surgical patient can be distinguished into
COVID-19-postive confirmed cases and COVID-19
suspected cases. Either case should be handled as posi-
tive until proved otherwise. Swabs and diagnostic tests
are requested as appropriate at admission but obtaining
results should not delay definitive surgical management.
Within colorectal emergency surgery, only life-threat-
ening emergencies should be treated (i.e. intestinal
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perforation, obstruction and bleeding), in order to spare
crucial resources for the management of the pandemic.
SARS-Cov-2 might potentially be released in the form
of aerosol with CO2 circulation in the abdominal cavity,
increasing the likelihood of nosocomial infections.
The use of laparoscopy in confirmed COVID-19
positive patient needing colorectal surgery should be
carefully considered. The potential downsides of mini-
mally-invasive surgery might include aerosolization of
virus that might increase viral spread, favoured by intra-
abdominal positive pressure during laparoscopy, while
for some procedures longer operative time prolongs
anaesthesia. However, laparoscopy can reduce the dis-
semination of aerosol compared to open surgery, espe-
cially when using electrocautery. Attention should be
paid, indeed, to limit the leakage of gas from the tro-
cars. Several methods have been suggested [8]. It is
important to use trocars with self-sealing type Hasson
and to make the incision as small as practicable. The
trocar trephine must be connected to negative pressure
suction with water seal. Before releasing the pneu-
moperitoneum or making an extraction incision the
insufflator must be turned off and the pneumoperi-
toneum must be emptied by negative pressure con-
nected to a water seal. The choice on whether to use
laparoscopy should be decided on a case-by-case basis
and be based on patient- and disease-related factors, as
well as surgeon expertise. In COVID-19 positive emer-
gency cases, we would suggest to adopt a selective use
of laparoscopy only if the appropriate equipment is
available and properly used. Pre-operative and intra-op-
erative collaboration with the multi-disciplinary and
anaesthetic team is vital.
COVID-19-positive patients with upper gastroin-
testinal bleeding with haemodynamic stability should
have all conservative management options exhausted
first prior endoscopy due to the high risk of aerosol
generating procedures. The requirement for such proce-
dures should be risk-assessed and deferred or delayed if
possible. If deemed essential, then full PPE are
required. Non-endoscopic interventions in the stable
patient with lower GI bleeding include angiography,
with or without angioembolization. Unstable patients
or ongoing bleeding patients should be considered for
laparotomy; however, outcomes are likely to be poor.
The management of large bowel perforations during
the pandemic should follow basic surgical principles,
however, open approach is recommended.
The management algorithm of complicated divertic-
ulitis should also not change [35], with a focus on max-
imising conservative options e.g. antibiotics where
possible. Procedures such as percutaneous drainage
should be risk-assessed. Laparoscopic lavage should be
strongly avoided preferring definitive surgery and source
control whenever required. Open abdomen should be
avoided, preferring one stage definitive procedures and
end stomas. Sigmoidectomy in emergency should be
performed as an open procedure and Hartmann pre-
ferred over an anastomosis in this particular situation.
It is recommended to be cautious when performing
anastomosis in the emergency setting in patients with
suspected or confirmed COVID-19, both because of
the high risk of complications (e.g. anastomotic leaks,
intra-abdominal collections) and for the subsequent
consumption of healthcare resources following an anas-
tomotic leak. Patients with COVID-19 infection might
be at increased risk of post-operative morbidity and
mortality [36].
Appendicitis management should be tailored to a
simple algorithm:
Perforated appendicitis needs urgent surgery which
should be performed via an open approach in proven
COVID-19 positive patients. Laparoscopy may be con-
sidered if the above mentioned precautions and devices
are available and properly installed in theatre.
Patients with image-proven non-perforated appen-
dicitis should be consented regarding an initial non-op-
erative approach with antibiotics and ambulatory care
where appropriate. Outpatient management of uncom-
plicated appendicitis with regular telephone (or remote)
follow up is ideal and has already been proven to be safe
and effective previous to this COVID-19 epidemic
[37]. Patients can be re-assessed in telephone clinics at
any time during follow up if symptoms are not resolv-
ing and readmission considered if deteriorating.
All emergency general surgery patients should be
tested for COVID-19 without delay. However, emer-
gency surgical management should not be delayed
whilst awaiting results with the rationale that all patients
during the pandemic should be considered to be
COVID-19 positive and precautions taken appropri-
ately.
In this context, the surgical theatre staff must be cor-
rectly trained to use personal protection equipment
(PPE) and all the procedures must be clearly defined
and standardized. The pandemic does not eliminate the
need to adhere to the perioperative surgical checklist
and should be prioritised to improve communication in
a high stress environment. Patients should be reviewed,
intubated and recovered within the theatre to restrict
contamination to just one room; the pathway to the
theatres must be the shortest possible on a previously
defined route, involving minimal contact with others.
The number of staff involved in the surgery should be
limited and the traffic in theatres should be restricted
[38].
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The preventing and protective measures adopted in
Northern Italian surgical departments are summarized
in Table 1.
Healthcare policy and Italian Government
Perspective
During an emergency, it is necessary to reframe and
reset the priorities, and the “yardsticks” that one would
use in everyday practice. During the COVID-19
outbreak, before it was declared pandemic, the Italian
Government promptly reacted with a timely planning
strategy to face the situation.
At the time of developing guidance suitable during
the COVID-19 crisis, the priority of the Government
was to protect the citizens, healthcare providers,
patients with COVID-19 and not patients with other
treatable conditions and those requiring emergency
treatment for acute diseases and trauma [4,7]. Due to
the lack of solid evidence regarding the pattern of
Table 1 Preventive and protective measures being adopted.
SETTING OF COVID SURGICAL THEATRE
• 2 teams: 1 inside, 1 outside the theatre
• team out: anaesthetic nurse/ ODP, scrub nurse, HCW
• team in: anaesthetic nurse/ ODP, scrub nurse, HCW, anaesthetist, surgical team
Level 2 Personal PPE in the theatre:
Pre-room: double hair cap, FFP 3 mask, overshoes, neck guard or surgical balaclava, use goggles or a silicone whole face mask/
face shield if using eyeglasses, sterile gown and gloves
ENTRANCE ORDER IN THEATRE
1 Scrub nurse/ HCW
2 Anaesthetist/ anaesthetic nurse
3 Patient (accompanied by the Surgical Ward staff from the area of origin who helps transfer the patient directly to the room on the surgi-
cal bed, through dedicated and marked COVID path) entrance in the Theatres Block from the emergency door adjacent to the Operat-
ing Theatre
4 Surgical team
Once Inside the Theatre:
Second sterile gown, second pair of gloves
EXIT FROM SURGICAL THEATRE
• The department (ward or ICU) of destination is alerted via Phone and prepares the bed; OUTSIDE staff physi-
cally goes to take the bed in the ward and brings it to the Operating Block
• INSIDE staff take the bed inside the operating room, and transfer the patient from the table to the bed
Procedure to leave the theatre
When leaving the theatre, the staff undresses in the filter area, then following a dedicated path. It is important to take off the
theatre gown with great care so as not to spread the virus and to remove the face mask as the last procedure and immediately put
on a clean one. The team goes to the changing room (the one closest to the operating room), there takes a whole-body shower




3 Anaesthetist + Anaesthetic Nurse without changing wear, they take the patient to the ward of destination (or ICU) following the
COVID dedicated path (which is then fully sanitized after operations are completed) together with the OUTSIDE HCW and Nurse
who precede them and act as "forerunners" opening the doors, pushing for the lift and making sure that the path is isolated.
4 INSIDE HCW sanitizes the operating room, then exit and change their scrubs following the same rules as above
HCW: Health Care Workers (porters - cleaners - assistants i.e. non nursing theatre staff)
ODP: Operating Department Practitioners
PPE: personal protective equipment
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infection, as well as the course of the disease and speci-
fic treatment for COVID-19, several strategic meetings
were scheduled, in order to dynamically adapt the nor-
mative to the rapidly evolving scenario.
The Italian Government chose to establish hospitals
dedicated to treating COVID-19 patients and other
hospitals suitable as referral centres to deal with surgical
emergencies and elective surgical procedures. These
centres were identified at a local level and established
after meetings of the Regional Council of each Italian
Region. The directives of the Central Government
required the local institution to identify several hospitals
per each region that would have been used for the
treatment of COVID-19 only, thereby better distribut-
ing the amount of work between centres, and allowing
a better allocation of resources. Redistributing and
reducing the workload during COVID-19 pandemic is
a necessary measure, given the reduced number of
working units available during the working shifts, due,
on the one hand, to strategies aimed at reducing the
social contacts and maintaining ward attendance to the
strictly necessary personnel, and, on the other hand, to
the contagion of healthcare professional, which require
14-day isolation. The reduced availability of instrumen-
tation and demand for intensive care beds further high-
lights the importance of adequately distributing tasks/
resources between centres.
The specific pathways that were adopted differed in
each Italian Region were based on the local extent of
outbreak. In Lombardy, a “Hub-and-Spoke” system
was designed with specific hubs identified correspond-
ing to their local expertise e.g. colorectal cancer.
Specific pathways of referrals were agreed e.g.
patients requiring surgery for cancer were regarded as
high priority. However, further sub-classification of pri-
ority was required in order to identify those needing
expedited surgical treatment and those in whom a
watchful waiting approach might be acceptable. During
the early phases of the crisis, a document was circulated
among the Health Directors of all hospitals of the
Region Lombardy, drafted by a panel of oncologists,
that reported a classification of priority suitable for
patients with colorectal cancer during the COVID-19
outbreak. Cancer patients were prioritized based on
tumour features and patient-associated factors (age and
comorbidities, graded by means of the American Society
of Anaesthesiologists’ [ASA] score). Three different cat-
egories of priorities were hence established, each identi-
fied with a colour:
• High priority (Red), including cancer-associated
emergencies, not amenable to endoscopic or non-sur-
gical treatment, with any ASA score if the patient is
< 80-year-of-age, or in ASA 1-2 in case of older
patients (patients > 80 year-of-age with ASA 3-4
graded as “intermediate priority”); surgery should be
performed within 2 weeks.
• Intermediate priority (yellow): cancers that are poten-
tially curable with surgery, without any pharmacologi-
cal, endoscopic, radiotherapy alternatives, in patients
of any age, with ASA 1 or 2 (patients above 80 year-
of-age with ASA 3-4 assigned to “low priority”); sur-
gery should be performed within 2 months
• Low priority (green): cancers amenable to pharmaco-
logical, endoscopic, radiotherapy AND early cancers
(i.e. T1N0) or with low aggressiveness; surgery can
be deferred over 2 months.
Specific tumour features associated with prognosis
were provided for each category, in order to aid the
decision-making.
It is not possible at the moment to draw any conclu-
sions about the performance of such measures, as the
decision of which specific elective procedures and the
number of procedures to be performed was not strictly
regulated. Speculating on data about the procedures
performed in each hospital or in each Region is of lim-
ited value at this stage and could be misleading, due to
the fact that most documents of discharge and clinical
charts might not be available.
Lastly, dedicated monitoring measures were put in
place, in order to detect any shortages in instrumenta-
tions or deficiencies which might jeopardize the ade-
quate provision of care or expose the healthcare
professionals to unacceptable working conditions, and
to identify the critical areas needing immediate action.
Discussions are in place on how to plan the post-
pandemic phase, which would need a careful reassess-
ment of the situation and might need the development
of a dedicated plan, which could probably require Inter-
national aids and collaboration.
Conclusions
COVID-19 pandemic is seriously threatening the struc-
ture of healthcare systems globally, and many interven-
tions will be needed to deal with the new scenario after
the crisis has been controlled. Hopefully, the necessity
will drive innovation [39]. The present manuscript was
designed to provide an overview on how some areas of
colorectal surgery can be reorganized during the emer-
gency. Far for being a definitive and authoritative
guideline, the contents of this document are to be
regarded as advice and guidance during a time of
unprecedented demand on global healthcare systems.
For those facing the crisis, it would be helpful to
consider an in-depth reorganization of the colorectal
service at a central and local level. The limited
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availability of surgical theatres, the reduced number of
staff members, the limited hospital beds and resources,
make it necessary to perform only prioritized elective
colorectal procedures. The conservative management of
COVID-19-positive patients with diseases of surgical
interest should be as conservative as possible, without
exposing the patients to unnecessary risks.
The surgical staff must adhere to strict perioperative
pathways and must receive adequate training and
instructions. Adherence to rules should be accompanied
by common sense and decisions should be taken swiftly
but based on efficient team-working and cross-specialty
collaboration.
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